• Mashup Score: 0
    Home - 8 month(s) ago

    Our speciality is in Cardiology – Clinical cardiology, Intervention cardiology, Pacing and Device management. Dr Mayayise’s practice strives to treat patients professionally, ethically and apply the most cost-effective solutions. Empowering referring doctors and township doctors with CPD meetings and feedback to all referring general practitioners and physicians. Dr Musa Mayayise is a member of South Africa Heart Association, South Africa Cardiovascular Intervention Society, South African Colleges of

    Tweet Tweets with this article
    • https://t.co/Gp9xQBIulM #Arrhythmias #CardiacArrest #Syncope #SuddenDeath #Bradycardia #Tachycardia #cardiologist #KnowYourPulse #EmergencyMedicalServices #ECG #Defibrillator https://t.co/QyeHmgYfsO

  • Mashup Score: 0
    Home - 8 month(s) ago

    Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease; however only 1 in 7 patients are diagnosed. Under-recognition of HCM and varied clinical presentation can cause diagnosis delays and misdiagnoses, thereby putting patients at greater risk of cardiovascular events. HCM is no longer a mystery. Evolving guideline recommendations have unlocked the potential for more timely diagnosis and advanced knowledge about pathogenesis has ushered in new and emerging therapeutic strategie

    Tweet Tweets with this article
    • đź“ť TEST YOUR SKILLS: Join experts November 11th and learn how to recognize the signs and symptoms associated with #HCM. Crack the case by clicking here: https://t.co/hHLgVe0B4s #CardioTwitter #CardioEd #Cardiologist #MedEd #CMEcredits https://t.co/b4bChvy3q0

  • Mashup Score: 2
    Home - 8 month(s) ago

    Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease; however only 1 in 7 patients are diagnosed. Under-recognition of HCM and varied clinical presentation can cause diagnosis delays and misdiagnoses, thereby putting patients at greater risk of cardiovascular events. HCM is no longer a mystery. Evolving guideline recommendations have unlocked the potential for more timely diagnosis and advanced knowledge about pathogenesis has ushered in new and emerging therapeutic strategie

    Tweet Tweets with this article
    • đź“ť TEST YOUR SKILLS: Join experts at #AHA23 November 11th and learn how to recognize the signs and symptoms associated with #HCM. Crack the case by clicking here: https://t.co/JBTacye5WY #CardioTwitter #CardioEd #Cardiologist #MedEd #CMEcredits https://t.co/e3GuJKaMJX

  • Mashup Score: 0
    Home - 8 month(s) ago

    Heart failure (HF) is a major cause of morbidity and mortality in the United States, with a prevalence that is expected to increase from about 6 million today to more than 8 million by 2030. A growing body of evidence pinpoints iron deficiency (ID) as an important comorbidity of HF, affecting more than 50% of patients with stable HF. Although the correction of ID is critical to improve outcomes in patients with HF, clinicians often overlook ID when providing HF care. Join our panel of experts for an

    Tweet Tweets with this article
    • SAVE THE DATE 🚨 for this event happening at #HFSA2023 October 7, 2023. Join experts as they discuss 🗣️ how to recognize and manage ID in patients with chronic Heart failure. Secure your seat now: https://t.co/YKdXCtgcpb #cardiotwitter #Cardiologist #HF #Meded #HeartFailure https://t.co/5wXq4zOPFz

  • Mashup Score: 0

    This week we delve into the world of electrophysiology and also single ventricle physiology when we review a recent work from the Stanford group on outcomes after the development of ventricular arrhythmias in the single ventricle Fontan patient. Just how worried should the clinician be when these are recorded on ambulatory ECG monitors? What associations exist between these arrhythmias and the…

    Tweet Tweets with this article
    • đź“Ł New Podcast! "Pediheart Podcast #259: Ventricular Arrhythmias In The Fontan Patient And Their Possible Meaning" on @Spreaker #arrhythmia #cardioed #cardiologia #cardiologie #cardiologist #cardiology #cardiotwitter #electrophysiology #fontan #study https://t.co/CpoQx8IvKQ

  • Mashup Score: 0

    May 17, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment of cardiovascular diseases, today announces the launch of its latest robotic platform – the R-One+. Robocath will showcase this new solution during the upcoming international EuroPCR conference in Paris (France), from May 16 to 19, at the company’s booth (M19, second floor)….

    Tweet Tweets with this article
    • @DAICeditor @Robocath The #robotic solution allows the #interventional #cardiologist to perform coronary #angioplasties by controlling the devices using an integrated control command unit located in the #cathlab or in the control room: https://t.co/iv41QrTOoW #EuroPCR #EuroPCR23

  • Mashup Score: 0

    During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it appeared to produce varying results with each patient. As someone who is left-handed, it took me slightly longer to feel comfortable using the system. Additionally, there was the constant worry of having an air embolism. I clearly remember my attendings questioning the quality of…

    Tweet Tweets with this article
    • @DAICeditor @acist_medical @MauriceAlston15 Dr. Maurice Alston, #interventional #cardiologist at #TennovaMedicalCenter in Cleveland, Tenn., discusses his experience with the #ACIST #CVi along with the data behind reduction in contrast volume & #AKI rates: https://t.co/B1N16CQmCQ